or Try an Advanced Search...

    Technical Analysis for OCX - OncoCyte Corporation

    Grade Last Price % Change Price Change
    F 2.61 -6.79% -0.19
    OCX closed down 6.79 percent on Friday, November 15, 2024, on 1.45 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical OCX trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    200 DMA Resistance Bearish -6.79%
    Volume Surge Other -6.79%
    Lower Bollinger Band Touch Weakness -6.79%
    Fell Below 200 DMA Bearish -11.22%
    Earnings Movers Other -11.22%
    Older End-of-Day Signals for OCX ...

       Recent Intraday Alerts

    Alert Time
    Down 5% 1 day ago
    Down 1 ATR 1 day ago
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    Down 3% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    OCX Chart by TradingView
    Basic chart:

    Profile

    OncoCyte Corporation focuses on developing diagnostic tests for the detection of breast, bladder, and lung cancers. The company was incorporated in 2009 and is based in Alameda, California. OncoCyte Corporation is a subsidiary of BioTime Inc.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Oncology Stem Cell Breast Cancer Cell Biology Lung Cancer Diagnostic Tests

    Is OCX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ...
    Nov 13 OncoCyte Corporation (OCX) Q3 2024 Earnings Call Transcript
    Nov 12 OncoCyte GAAP EPS of -$0.98 misses by $0.54, revenue of $0.11M misses by $0.06M
    Nov 12 Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 11 OncoCyte Q3 Earnings Preview
    Nov 11 What to Expect from OncoCyte's Earnings
    Nov 6 Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
    Oct 16 OncoCyte files for secondary stock offering
    Oct 16 Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
    See more OCX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.34
    52 Week Low 2.285
    Average Volume 39,452
    200-Day Moving Average 2.95
    50-Day Moving Average 3.02
    20-Day Moving Average 2.97
    10-Day Moving Average 2.86
    Average True Range 0.16
    RSI (14) 30.07
    ADX 22.83
    +DI 10.94
    -DI 24.86
    Chandelier Exit (Long, 3 ATRs) 2.77
    Chandelier Exit (Short, 3 ATRs) 3.09
    Upper Bollinger Bands 3.22
    Lower Bollinger Band 2.71
    Percent B (%b) -0.18
    BandWidth 17.52
    MACD Line -0.07
    MACD Signal Line -0.04
    MACD Histogram -0.027
    Fundamentals Value
    Market Cap 21.56 Million
    Num Shares 8.26 Million
    EPS -3.37
    Price-to-Earnings (P/E) Ratio -0.77
    Price-to-Sales 16.72
    Price-to-Book 0.63
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.90
    Resistance 3 (R3) 2.92 2.86 2.85
    Resistance 2 (R2) 2.86 2.78 2.84 2.83
    Resistance 1 (R1) 2.73 2.74 2.70 2.71 2.82
    Pivot Point 2.67 2.67 2.65 2.65 2.67
    Support 1 (S1) 2.54 2.59 2.51 2.52 2.40
    Support 2 (S2) 2.48 2.55 2.46 2.39
    Support 3 (S3) 2.35 2.48 2.37
    Support 4 (S4) 2.33